The messenger RNA (mRNA) market is projected to grow significantly, reaching an estimated value of $20.99 billion by 2035, driven largely by advancements made during the COVID-19 pandemic. This growth is supported by increased investments and innovations in mRNA technologies, with applications expanding into oncology, genetic disorders, and personalized medicine. Key recent developments include the approval of updated mRNA vaccines by Moderna and Pfizer, strategic partnerships for enhancing mRNA formulations, and increased demand for adaptable vaccines against infectious diseases. Challenges in manufacturing and regulatory frameworks remain, while opportunities for innovation in gene editing continue to emerge.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://finance.yahoo.com/sectors/healthcare/articles/messenger-rna-mrna-market-projected-160100770.html
